Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 843.6 INR 0.51% Market Closed
Market Cap: 151.1B INR

Intrinsic Value

The intrinsic value of one NATCOPHARM stock under the Base Case scenario is 739.56 INR. Compared to the current market price of 843.6 INR, Natco Pharma Ltd is Overvalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NATCOPHARM Intrinsic Value
739.56 INR
Overvaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Natco Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
NATCOPHARM
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for NATCOPHARM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Natco Pharma Ltd
NSE:NATCOPHARM
IN
Pharmaceuticals
Market Cap
151.1B INR
IPO
Jan 23, 1995
IN
Pharmaceuticals
Market Cap
151.1B INR
IPO
Jan 23, 1995
Price
₹false
EPS
₹false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NATCOPHARM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Natco Pharma Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Natco Pharma Ltd

Current Assets 50B
Cash & Short-Term Investments 24.6B
Receivables 14.5B
Other Current Assets 10.9B
Non-Current Assets 32.4B
Long-Term Investments 3.7B
PP&E 25.4B
Intangibles 2.4B
Other Non-Current Assets 995m
Efficiency

Free Cash Flow Analysis
Natco Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Natco Pharma Ltd

Revenue
42.8B INR
Cost of Revenue
-5.8B INR
Gross Profit
36.9B INR
Operating Expenses
-17.4B INR
Operating Income
19.5B INR
Other Expenses
-877m INR
Net Income
18.7B INR
Fundamental Scores

NATCOPHARM Profitability Score
Profitability Due Diligence

Natco Pharma Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
ROE is Increasing
73/100
Profitability
Score

Natco Pharma Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

NATCOPHARM Solvency Score
Solvency Due Diligence

Natco Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Natco Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NATCOPHARM Price Targets Summary
Natco Pharma Ltd

Wall Street analysts forecast NATCOPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 1 123.36 INR with a low forecast of 717.1 INR and a high forecast of 1 758.75 INR.

Lowest
Price Target
717.1 INR
15% Downside
Average
Price Target
1 123.36 INR
33% Upside
Highest
Price Target
1 758.75 INR
108% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NATCOPHARM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NATCOPHARM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one NATCOPHARM stock?

The intrinsic value of one NATCOPHARM stock under the Base Case scenario is 739.56 INR.

Is NATCOPHARM stock undervalued or overvalued?

Compared to the current market price of 843.6 INR, Natco Pharma Ltd is Overvalued by 12%.

Back to Top